Marcus J Drake Selected Research

Solifenacin Succinate

12/2017	Assessing Preference-Based Outcome Measures for Overactive Bladder: An Evaluation of Patient-Reported Outcome Data from the BESIDE Clinical Trial.
12/2017	Treating Overactive Bladder in Older Patients with a Combination of Mirabegron and Solifenacin: A Prespecified Analysis from the BESIDE Study.
6/2017	Adding Mirabegron to Solifenacin to Treat Overactive Bladder Has Little Impact on Postvoid Residual Volume or Urinary Retention Risk.
5/2017	Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add-on mirabegron therapy to solifenacin (BESIDE).
1/2016	Mirabegron as Add-On Treatment to Solifenacin in Patients with Incontinent Overactive Bladder and an Inadequate Response to Solifenacin Monotherapy: Responder Analyses and Patient-Reported Outcomes from the BESIDE Study [corrected].
1/2016	Responder and health-related quality of life analyses in men with lower urinary tract symptoms treated with a fixed-dose combination of solifenacin and tamsulosin oral-controlled absorption system: results from the NEPTUNE study.
1/2016	Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-Week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE).
2/2015	Long-term safety and efficacy of single-tablet combinations of solifenacin and tamsulosin oral controlled absorption system in men with storage and voiding lower urinary tract symptoms: results from the NEPTUNE Study and NEPTUNE II open-label extension.
12/2013	Combination therapy with solifenacin and tamsulosin oral controlled absorption system in a single tablet for lower urinary tract symptoms in men: efficacy and safety results from the randomised controlled NEPTUNE trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marcus J Drake Research Topics

Disease

18	Lower Urinary Tract Symptoms 01/2022 - 11/2008
17	Overactive Urinary Bladder (Overactive Bladder) 01/2022 - 07/2008
12	Nocturia 01/2022 - 11/2017
6	Stress Urinary Incontinence 01/2021 - 04/2010
5	Urinary Incontinence 01/2021 - 04/2013
5	Urinary Retention 01/2021 - 11/2008
4	Polyuria 01/2022 - 11/2017
4	Hypertension (High Blood Pressure) 01/2022 - 10/2015
3	Inflammation (Inflammations) 01/2022 - 10/2013
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2022 - 01/2016
2	Fibrosis (Cirrhosis) 11/2018 - 01/2018
2	Multiple Sclerosis 08/2018 - 01/2018
2	Pelvic Pain 01/2018 - 04/2017
2	Pain (Aches) 01/2018 - 01/2014
1	Parasomnias (Parasomnia) 01/2022
1	Diabetes Insipidus 01/2022
1	Diabetes Mellitus 01/2022
1	Endocrine System Diseases (Endocrine Diseases) 01/2022
1	Heart Failure 01/2022
1	Hyperplasia 01/2022
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022
1	Sleep Wake Disorders 01/2022
1	Thyroid Diseases (Thyroid Disease) 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020
1	Neoplasms (Cancer) 11/2018
1	Spinal Cord Injuries (Spinal Cord Injury) 11/2018
1	Ataxia (Dyssynergia) 11/2018
1	Radiation Fibrosis Syndrome (Radiation Fibrosis) 11/2018
1	Cystitis 11/2018
1	Fatigue 01/2018
1	Tachycardia (Tachyarrhythmias) 05/2017
1	Headache (Headaches) 10/2015
1	Constipation 10/2015
1	Liver Failure 10/2015
1	Renal Insufficiency (Renal Failure) 10/2015
1	Prostatic Neoplasms (Prostate Cancer) 06/2015
1	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 08/2014
1	Infections 01/2014
1	Pathologic Processes 10/2013

Drug/Important Bio-Agent (IBA)

9	Solifenacin Succinate FDA Link 12/2017 - 12/2013
8	Muscarinic AntagonistsIBA 01/2021 - 10/2012
8	mirabegronIBA 12/2017 - 10/2015
4	Botulinum Toxins (Botulinum Toxin)IBA 01/2021 - 07/2008
4	Tamsulosin (Flomax)FDA LinkGeneric 01/2019 - 12/2013
3	SaltsIBA 01/2022 - 01/2022
3	Cholinergic Antagonists (Anticholinergics)IBA 11/2017 - 05/2017
3	TabletsIBA 01/2017 - 12/2013
2	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 01/2022 - 11/2017
2	CollagenIBA 01/2022 - 11/2018
2	Phosphodiesterase 5 InhibitorsIBA 01/2021 - 01/2016
2	Pharmaceutical PreparationsIBA 01/2020 - 11/2017
2	MelatoninIBA 08/2018 - 01/2018
2	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2018 - 04/2017
2	Type A Botulinum Toxins (Botox)FDA Link 11/2017 - 10/2017
2	Adrenergic Receptors (Adrenergic Receptor)IBA 05/2017 - 10/2015
1	Soluble Guanylyl CyclaseIBA 01/2022
1	AlbuminsIBA 01/2022
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2022
1	CreatinineIBA 01/2022
1	DiureticsIBA 01/2022
1	ElectrolytesIBA 01/2022
1	Heme (Haem)IBA 01/2022
1	LithiumIBA 01/2022
1	Urea (Carbamide)FDA LinkGeneric 01/2022
1	mesoglycanIBA 01/2021
1	Sildenafil Citrate (Viagra)FDA Link 01/2019
1	alfuzosin (UroXatral)FDA Link 01/2019
1	Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA 11/2018
1	LM11A-31IBA 11/2018
1	NitrogenIBA 11/2018
1	Therapeutic UsesIBA 11/2018
1	Oxygen (Dioxygen)IBA 11/2018
1	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 11/2018
1	RelaxinIBA 01/2018
1	Vitamin D FDA LinkGeneric 01/2018
1	EndostatinsIBA 01/2018
1	Hormones (Hormone)IBA 01/2018
1	AntioxidantsIBA 12/2016
1	Prostate-Specific Antigen (Semenogelase)IBA 06/2015
1	SmokeIBA 01/2015
1	AndrogensIBA 10/2013

Therapy/Procedure

20	Therapeutics 01/2022 - 10/2012
5	Conservative Treatment 01/2022 - 01/2015
5	Prostatectomy (Retropubic Prostatectomy) 01/2021 - 04/2010
3	Catheters 01/2021 - 01/2019
2	Artificial Urinary Sphincter 01/2019 - 04/2013
2	Bathroom Equipment 01/2018 - 12/2017
1	Polypharmacy 01/2022
1	Transurethral Resection of Prostate (TURP) 01/2021
1	Electrodes (Electrode) 01/2021
1	Suburethral Slings (Tension-Free Vaginal Tape) 01/2021
1	Aftercare (After-Treatment) 11/2020
1	Radiotherapy 11/2018
1	Cystectomy 11/2018
1	Injections 01/2018
1	Drug Tapering 10/2015
1	Autonomic Denervation 08/2014
1	Stents 01/2014
1	Drug Therapy (Chemotherapy) 10/2013